 Maki Nakayama
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantigens | 11 | 2019 | 374 | 3.340 |
Why?
| | Receptors, Antigen, T-Cell | 10 | 2020 | 499 | 3.160 |
Why?
| | Insulin | 14 | 2019 | 1972 | 1.890 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2019 | 2820 | 1.700 |
Why?
| | CD4-Positive T-Lymphocytes | 8 | 2020 | 996 | 1.440 |
Why?
| | Peptide Fragments | 9 | 2019 | 689 | 1.430 |
Why?
| | T-Lymphocytes | 7 | 2020 | 1648 | 1.350 |
Why?
| | Hybridomas | 5 | 2020 | 183 | 1.100 |
Why?
| | Proinsulin | 3 | 2016 | 48 | 1.080 |
Why?
| | CD3 Complex | 2 | 2020 | 95 | 1.070 |
Why?
| | Epitopes | 2 | 2020 | 381 | 1.030 |
Why?
| | Protein Precursors | 2 | 2016 | 123 | 0.960 |
Why?
| | Autoimmunity | 8 | 2020 | 692 | 0.910 |
Why?
| | Retroviridae | 1 | 2020 | 99 | 0.880 |
Why?
| | Immunoassay | 1 | 2020 | 100 | 0.860 |
Why?
| | Insulin-Secreting Cells | 3 | 2019 | 296 | 0.840 |
Why?
| | Lymphocyte Activation | 4 | 2020 | 1194 | 0.840 |
Why?
| | Immunomodulation | 1 | 2020 | 81 | 0.830 |
Why?
| | Antigens | 2 | 2018 | 308 | 0.790 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 176 | 0.770 |
Why?
| | Mice, Inbred NOD | 13 | 2019 | 519 | 0.760 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2018 | 68 | 0.740 |
Why?
| | Allografts | 1 | 2018 | 97 | 0.730 |
Why?
| | Peptides | 2 | 2020 | 839 | 0.660 |
Why?
| | Islets of Langerhans | 5 | 2019 | 627 | 0.660 |
Why?
| | Graft Rejection | 1 | 2018 | 644 | 0.580 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2012 | 296 | 0.520 |
Why?
| | Macromolecular Substances | 1 | 2010 | 231 | 0.440 |
Why?
| | Urogenital Abnormalities | 2 | 2020 | 36 | 0.410 |
Why?
| | Histocompatibility Antigens Class II | 4 | 2018 | 360 | 0.410 |
Why?
| | Mice | 17 | 2020 | 14765 | 0.400 |
Why?
| | Animals | 21 | 2020 | 34264 | 0.360 |
Why?
| | C-Peptide | 2 | 2018 | 130 | 0.350 |
Why?
| | Neoplasms | 1 | 2020 | 1913 | 0.350 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2018 | 46 | 0.330 |
Why?
| | Amino Acid Substitution | 3 | 2020 | 303 | 0.320 |
Why?
| | Alanine | 1 | 2004 | 73 | 0.310 |
Why?
| | Histocompatibility Antigens | 2 | 2020 | 90 | 0.300 |
Why?
| | Autoantibodies | 3 | 2010 | 1144 | 0.300 |
Why?
| | Transgenes | 1 | 2004 | 190 | 0.280 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2020 | 159 | 0.280 |
Why?
| | Mutation | 3 | 2020 | 3174 | 0.230 |
Why?
| | Mice, Knockout | 5 | 2020 | 2809 | 0.230 |
Why?
| | Urinary Tract | 1 | 2020 | 26 | 0.230 |
Why?
| | Cross Reactions | 1 | 2020 | 148 | 0.220 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 90 | 0.210 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 180 | 0.210 |
Why?
| | Forkhead Transcription Factors | 1 | 2020 | 180 | 0.210 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2011 | 187 | 0.200 |
Why?
| | Genes, Reporter | 1 | 2020 | 304 | 0.200 |
Why?
| | Genetic Vectors | 1 | 2020 | 305 | 0.200 |
Why?
| | Genotype | 1 | 2004 | 2038 | 0.200 |
Why?
| | Fraser Syndrome | 1 | 2018 | 1 | 0.200 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2013 | 214 | 0.190 |
Why?
| | Disease Susceptibility | 1 | 2020 | 299 | 0.190 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2018 | 18 | 0.190 |
Why?
| | Chromogranin A | 1 | 2018 | 38 | 0.190 |
Why?
| | Immunization | 1 | 2020 | 375 | 0.180 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2012 | 45 | 0.180 |
Why?
| | Recombination, Genetic | 1 | 2018 | 179 | 0.180 |
Why?
| | Repressor Proteins | 1 | 2020 | 365 | 0.180 |
Why?
| | Humans | 14 | 2020 | 104249 | 0.170 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 439 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2018 | 309 | 0.160 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 228 | 0.160 |
Why?
| | Immunotherapy | 1 | 2019 | 397 | 0.160 |
Why?
| | Protein Binding | 4 | 2020 | 2098 | 0.150 |
Why?
| | HLA Antigens | 1 | 2015 | 235 | 0.150 |
Why?
| | Mice, Transgenic | 4 | 2009 | 2151 | 0.130 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1409 | 0.130 |
Why?
| | Complementarity Determining Regions | 1 | 2012 | 51 | 0.130 |
Why?
| | Heterozygote | 2 | 2020 | 275 | 0.130 |
Why?
| | Crosses, Genetic | 2 | 2018 | 149 | 0.120 |
Why?
| | Transcription Factors | 1 | 2020 | 1593 | 0.120 |
Why?
| | Germ-Line Mutation | 1 | 2012 | 113 | 0.120 |
Why?
| | Mice, SCID | 2 | 2018 | 334 | 0.120 |
Why?
| | Homozygote | 2 | 2018 | 187 | 0.120 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 990 | 0.120 |
Why?
| | Organophosphorus Compounds | 1 | 2011 | 76 | 0.120 |
Why?
| | Prediabetic State | 1 | 2013 | 210 | 0.120 |
Why?
| | Glycine | 1 | 2011 | 156 | 0.110 |
Why?
| | Antigen Presentation | 1 | 2011 | 204 | 0.110 |
Why?
| | Adoptive Transfer | 2 | 2013 | 243 | 0.110 |
Why?
| | Major Histocompatibility Complex | 1 | 2010 | 183 | 0.110 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 28 | 0.100 |
Why?
| | Spleen | 2 | 2013 | 566 | 0.090 |
Why?
| | Pedigree | 2 | 2020 | 519 | 0.090 |
Why?
| | Child | 4 | 2020 | 15648 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2236 | 0.090 |
Why?
| | Signal Transduction | 1 | 2020 | 4845 | 0.080 |
Why?
| | Poly I-C | 1 | 2005 | 54 | 0.080 |
Why?
| | Ovum | 1 | 2004 | 38 | 0.080 |
Why?
| | Microinjections | 1 | 2004 | 131 | 0.080 |
Why?
| | Thymus Gland | 2 | 2019 | 249 | 0.080 |
Why?
| | Disease Progression | 2 | 2018 | 2341 | 0.080 |
Why?
| | Female | 6 | 2020 | 59707 | 0.070 |
Why?
| | Young Adult | 2 | 2019 | 10261 | 0.070 |
Why?
| | Pancreas | 2 | 2019 | 232 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2005 | 205 | 0.070 |
Why?
| | Conserved Sequence | 2 | 2018 | 226 | 0.070 |
Why?
| | Adolescent | 2 | 2019 | 17541 | 0.060 |
Why?
| | Models, Biological | 1 | 2010 | 1842 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2566 | 0.060 |
Why?
| | Amphibian Proteins | 1 | 2020 | 2 | 0.060 |
Why?
| | Whole Exome Sequencing | 1 | 2020 | 62 | 0.060 |
Why?
| | Morpholinos | 1 | 2020 | 25 | 0.060 |
Why?
| | Xenopus | 1 | 2020 | 126 | 0.060 |
Why?
| | Time Factors | 1 | 2012 | 7066 | 0.050 |
Why?
| | Larva | 1 | 2020 | 188 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1260 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 81 | 0.050 |
Why?
| | Models, Molecular | 2 | 2018 | 1583 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2018 | 68 | 0.050 |
Why?
| | Lysosomes | 1 | 2019 | 101 | 0.050 |
Why?
| | Urogenital System | 1 | 2018 | 15 | 0.050 |
Why?
| | Consanguinity | 1 | 2018 | 47 | 0.050 |
Why?
| | Clone Cells | 1 | 2018 | 248 | 0.050 |
Why?
| | Protein Domains | 1 | 2019 | 206 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2018 | 4339 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 123 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2018 | 414 | 0.040 |
Why?
| | Exons | 1 | 2018 | 318 | 0.040 |
Why?
| | Immune Tolerance | 1 | 2019 | 339 | 0.040 |
Why?
| | Family | 1 | 2020 | 542 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 480 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2013 | 4997 | 0.040 |
Why?
| | Blood Glucose | 1 | 2005 | 1689 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1265 | 0.040 |
Why?
| | Models, Animal | 1 | 2018 | 392 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2018 | 906 | 0.040 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 422 | 0.040 |
Why?
| | Male | 4 | 2020 | 58392 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2020 | 3225 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2018 | 846 | 0.030 |
Why?
| | Baculoviridae | 1 | 2011 | 47 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2770 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2011 | 75 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 388 | 0.030 |
Why?
| | Antigens, Bacterial | 1 | 2011 | 129 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2013 | 460 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 555 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2009 | 55 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 915 | 0.020 |
Why?
| | Alleles | 1 | 2011 | 875 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3163 | 0.020 |
Why?
| | Infant | 1 | 2020 | 7629 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1182 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 163 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 9106 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 3197 | 0.020 |
Why?
| | Chronic Disease | 1 | 2008 | 1686 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2005 | 612 | 0.010 |
Why?
| | Gene Expression | 1 | 2005 | 1525 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2291 | 0.010 |
Why?
| | Adult | 1 | 2019 | 30359 | 0.010 |
Why?
| | Aging | 1 | 2005 | 1668 | 0.010 |
Why?
|
|
Nakayama's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|